
Reset all filters
01 2ABBVIE
Reset all filters
01 29139536
Reset all filters
01 2Blank
Reset all filters
01 2Blank
Reset all filters
01 22028-11-09
Patent Expiration Date : 2028-11-09
DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR
US Patent Number : 9139536
Drug Substance Claim :
Drug Product Claim :
Application Number : 206619
Patent Use Code : U-1753
Delist Requested :
Patent Use Description : TREATMENT OF HCV INFEC...
Patent Expiration Date : 2028-11-09
Patent Expiration Date : 2028-11-09
DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR
US Patent Number : 9139536
Drug Substance Claim :
Drug Product Claim :
Application Number : 208624
Patent Use Code : U-1753
Delist Requested :
Patent Use Description : TREATMENT OF HCV INFEC...
Patent Expiration Date : 2028-11-09